GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » Net Current Asset Value

Target Group (Target Group) Net Current Asset Value : $-0.02 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Target Group Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Target Group's net current asset value per share for the quarter that ended in Dec. 2023 was $-0.02.

The historical rank and industry rank for Target Group's Net Current Asset Value or its related term are showing as below:

CBDY's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.575
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Target Group Net Current Asset Value Historical Data

The historical data trend for Target Group's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group Net Current Asset Value Chart

Target Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.03 -0.02 -0.02 -0.02

Target Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.02 -0.02 -0.02

Competitive Comparison of Target Group's Net Current Asset Value

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Target Group's Price-to-Net-Current-Asset-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Target Group's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Target Group's Price-to-Net-Current-Asset-Value falls into.



Target Group Net Current Asset Value Calculation

Target Group's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3.094-15.814-0-0)/617.026
=-0.02

Target Group's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3.094-15.814-0-0)/617.026
=-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Target Group  (OTCPK:CBDY) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Target Group Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Target Group's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Target Group (Target Group) Business Description

Traded in Other Exchanges
N/A
Address
20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.
Executives
Barry Alan Katzman director 36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone director 564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte director 18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam director 42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali officer: CFO 134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr director, 10 percent owner, officer: President 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann director, 10 percent owner, officer: CEO 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust 10 percent owner 52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada) 10 percent owner 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr other: See Remarks 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy director, 10 percent owner, officer: president 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: vice president 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Target Group (Target Group) Headlines

From GuruFocus

Canary RX Receives its Health Canada Sales License

By PRNewswire PRNewswire 09-15-2021